Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 83 Breast Neoplasms 52 Salivary Gland Neoplasms 3 Prostate Adenocarcinoma 3 Neoplasms 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Osteoporosis 2 Neoplasm Metastasis 2 Leiomyoma 2 Breast Neoplasms, Male 2 Advanced Breast Cancer 2 Stage I Prostate Adenocarcinoma AJCC v7 1 Sexual Dysfunctions, Psychological 1 Sexual Dysfunction, Physiological 1 Sarcopenia 1 Radiation Injuries 1 Primary Ovarian Insufficiency 1 Primary Dysautonomias 1 Patients With T1-4 Advanced Prostate Cancer 1 Patient Compliance 1 PSA Level Greater Than Two 1 Ovarian Neoplasms 1 Myofibroma 1 Lymphatic Metastasis 1 Kidney Diseases 1 Hypertension 1 Hyperlipidemias 1 Hot Flashes 1 Hormone-sensitive Metastatic Breast Cancer 1

Interventions

Cyclophosphamide 165 fludarabine phosphate 110 Peripheral Blood Stem Cell Transplantation 94 Mycophenolic Acid 88 Whole-Body Irradiation 81 Etoposide 81 Tacrolimus 73 Busulfan 68 Melphalan 67 Filgrastim 66 fludarabine 62 Radiotherapy 56 Doxorubicin 54 Cyclosporine 54 Rituximab 50 Brentuximab Vedotin 48 Antilymphocyte Serum 47 Granulocyte Colony-Stimulating Factor 42 Vinblastine 41 Methotrexate 38 Dacarbazine 37 Cytarabine 35 Gemcitabine 34 Nivolumab 30 Bleomycin 29 Carmustine 28 Vincristine 25 Prednisone 25 Sirolimus 24 Bendamustine Hydrochloride 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hodgkin Disease × Goserelin × Clear all

NCT01014507 2012-06-25

PROFE

University of Cologne

Phase 2 Completed

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡